Based on our study, a GLP-1 receptor agonist-based weight-loss program appears to be superior to non-GLP-1 receptor agonist-based weight-loss programs and intensive lifestyle modification alone for treating post-bariatric surgery weight regain, regardless of surgery type, the researchers wrote
This gives people more time to implement the habits and lifestyle changes needed to keep the weight off longterm
BMJ 2016;352:i581.ArticlePubMedPMC 57
Optimizing Dosing Optimization for Continued Results Many patients remain on an early or suboptimal dose of their GLP-1 medication for extended periods
With the launch of Noveltreat and Sematrinity, our endeavour is to provide a high-quality, affordable therapy to a wider patient community in India, said Kirti Ganorkar, managing director of Sun Pharmaceutical in a statement
They mimic a gut hormone to improve blood sugar control and reduce appetite